Raia Drogasil S.A.
RADLYOTCHealthcare● Active
$3.52
+$0.08(+2.33%)
Market Cap$6.2B
P/E Ratio—
52W High$5.342
52W Low$2.22
Raia Drogasil S.A. (RADLY) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · RADLY · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $43.38B | $38.86B | $33.97B | $29.07B | $24.13B |
| Cost of Revenue | $32.64B | $27.31B | $23.77B | $20.26B | $16.92B |
| Gross Profit | $10.74B | $11.55B | $10.21B | $8.81B | $7.21B |
| Gross Margin %(computed) | 24.75% | 29.72% | 30.04% | 30.31% | 29.87% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $1.57B | $1.50B | $1.25B | $0.91B |
| Total Operating Expenses | $8.15B | $9.18B | $8.13B | $6.98B | $5.83B |
| Operating Income | $2.59B | $2.37B | $2.08B | $1.48B | $1.22B |
| Operating Margin %(computed) | 5.96% | 6.09% | 6.12% | 5.09% | 5.07% |
| Interest Income | $0.02B | $0.00B | $0.05B | $0.00B | $0.00B |
| Interest Expense | $1.05B | $0.81B | $0.74B | $0.29B | $0.23B |
| Income Before Tax | $1.42B | $1.42B | $1.22B | $1.19B | $0.99B |
| Income Tax Expense | $0.14B | $0.21B | $0.13B | $0.18B | $0.22B |
| Net Income | $1.27B | $1.20B | $1.05B | $1.00B | $0.75B |
| Net Margin %(computed) | 2.93% | 3.08% | 3.11% | 3.43% | 3.12% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.77 | $0.73 | $0.62 | $0.58 | $0.44 |
| Wtd Avg Shares | 1.65B | 1.65B | 1.70B | 1.71B | 1.72B |
| EBITDA | $4.56B | $3.14B | $2.75B | $2.45B | $2.63B |
| EBITDA Margin %(computed) | 10.51% | 8.08% | 8.10% | 8.44% | 10.90% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · BRL · B
Explore more Raia Drogasil S.A. data
About Raia Drogasil S.A. (RADLY) Income Statement
Raia Drogasil S.A. (RADLY) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, RADLY reported revenue of $43.38B, gross profit of $10.74B (gross margin 24.75%), and net income of $1.27B — a net profit margin of 2.93%.
Frequently asked questions
RADLY · 4 questionsRaia Drogasil S.A. (RADLY) reported revenue of $43.38B for 2025, up 11.6% year-over-year.
RADLY revenueRADLY salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09